Breaking News Instant updates and real-time market news.

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:28
08/23/19
08/23
07:28
08/23/19
07:28

VMware price target lowered to $190 from $210 at RBC Capital

RBC Capital analyst Matthew Hedberg lowered his price target on VMware (VMW) to $190, saying its Q2 results were "good" though the below-consensus outlook was impacted by some mix-shift due to "increasing strength in hybrid cloud/SaaS". The analyst is keeping his Outperform rating on the shares however, stating that more importantly, the company's FY20 guidance was unchanged. Hedberg also believes that VMware's acquisitions of Pivotal Software (PVTL) and Carbon Black (CBLK) will bring "application modernization and endpoint security" to its platform.

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

VMW VMware
$148.15

0.11 (0.07%)

08/23/19
JEFF
08/23/19
NO CHANGE
Target $198
JEFF
Buy
VMware price target lowered to $198 from $213 at Jefferies
Jefferies analyst John DiFucci lowered his price target on VMware (VMW) to $198, saying that while the company posted a "solid" Q2, its Q3 guidance was affected by the revenue mix shift to "more ratable business". The analyst is keeping his Buy rating on the stock and contends that investors may be over-estimating the decline of its core compute business which has been "more resilient" lately. DiFucci further contends that VMware's deals with public cloud providers "extend the relevance" of its core business. The analyst adds that the company's Pivotal Software (PVTL) acquisition "makes sense" and comes at an "attractive" value, while the deal for Carbon Black (CBLK) comes with some "execution risk" because of the high level of competition in the corporate endpoint security sector.
08/23/19
KEYB
08/23/19
NO CHANGE
Target $182
KEYB
Overweight
VMware price target lowered to $182 from $214 at KeyBanc
KeyBanc analyst Alex Kurtz lowered his price target on VMware (VMW) to $182, saying the company generated "solid" billings upside with its Q2 results, but its announced acquisitions of Pivotal Software (PVTL) and Carbon Black (CBLK) may lead to some investor concerns with execution and use of funds. The analyst is keeping his Overweight rating on the shares longer term and sees the deals reflecting VMware's intentions to "modernize and secure" the company's core compute franchise.
08/23/19
OPCO
08/23/19
NO CHANGE
Target $200
OPCO
Outperform
VMware price target lowered to $200 from $220 at Oppenheimer
Oppenheimer analyst Ittai Kidron lowered his price target for VMware (VMW) to $200 from $220 and maintained an Outperform rating after the company delivered a "solid" quarter with "strong" billings metrics, adjusted guidance for Q3 and FY20 and announced plans to acquire Pivotal Software (PVTL) and Carbon Black (CBLK). In a research note to investors, Kidron says he has "mixed feelings" and is "less constructive" on Pivotal's deal merits, but understands VMware's efforts to complement its infrastructure-oriented portfolio with modern application development and endpoint security assets. He believes the shares will likely remain range-bound until VMware proves it can execute and drive top-line growth synergies.
08/23/19
FBCO
08/23/19
NO CHANGE
Target $170
FBCO
Neutral
VMware price target lowered to $170 from $185 at Credit Suisse
Credit Suisse analyst Brad Zelnick lowered his price target for VMware (VMW) to $170 from $185 and maintained a Neutral rating following the company's "mixed" Q2 results and its intention to acquire Pivotal Software (PVTL) and Carbon Black (CBLK). In view of the rising SaaS mix, Zelnick says he prefers RPO bookings growth of 13% year-over-year as his preferred metric for the overall business fundamentals.
PVTL Pivotal Software
$13.69

0.01 (0.07%)

08/23/19
RAJA
08/23/19
NO CHANGE
Target $185
RAJA
Outperform
VMware price target lowered to $185 from $206 at Raymond James
Raymond James analyst Michael Turits lowered his price target on VMware (VMW) to $185 to reflect the lighter than expected Q3 guidance, with license revenue forecast coming in "light on a mix shift to ratable SaaS". The analyst is keeping his Outperform rating howerver, stating that VMware's growth remains otherwise "impressive" at 12% for revenue, 13% bookings, and 17% billings in spite of the weaker enterprise IT spending environment which has weighed on other on-premise server and networking companies. Turits further states that the acquisitions of Pivotal Software (PVTL) and Carbon Black (CBLK) may not be "transformative" but are "logically incremental" and made with "reasonable valuations".
CBLK Carbon Black
$24.52

1.77 (7.78%)

TODAY'S FREE FLY STORIES

AGR

Avangrid

$50.85

0.06 (0.12%)

07:11
09/17/19
09/17
07:11
09/17/19
07:11
Hot Stocks
Avangrid Renewables to sell stake in AZ wind farm, solar projects »

Avangrid Renewables, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 02

    Oct

  • 10

    Nov

  • 10

    Nov

CRSP

Crispr Therapeutics

$49.70

2.08 (4.37%)

07:09
09/17/19
09/17
07:09
09/17/19
07:09
Hot Stocks
Crispr Therapeutics, ViaCyte present data from regenerative medicine program »

CRISPR Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATU

Actuant

$26.23

0.03 (0.11%)

07:09
09/17/19
09/17
07:09
09/17/19
07:09
Downgrade
Actuant rating change  »

Actuant downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AAPL

Apple

$219.88

1.17 (0.53%)

, GLW

Corning

$30.04

-0.12 (-0.40%)

07:07
09/17/19
09/17
07:07
09/17/19
07:07
Hot Stocks
Apple awards additional $250M to Corning for glass processes »

Apple (AAPL) announced it…

AAPL

Apple

$219.88

1.17 (0.53%)

GLW

Corning

$30.04

-0.12 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIR

Circor

$37.27

0.29 (0.78%)

07:06
09/17/19
09/17
07:06
09/17/19
07:06
Upgrade
Circor rating change  »

Circor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

APLT

Applied Therapeutics

$9.20

-0.5 (-5.15%)

07:05
09/17/19
09/17
07:05
09/17/19
07:05
Hot Stocks
Applied Therapeutics to present data highlighting AT-001 at EASD meeting »

Applied Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAPR

Capricor Therapeutics

$2.70

-0.03 (-1.10%)

07:03
09/17/19
09/17
07:03
09/17/19
07:03
Hot Stocks
Capricor Therapeutics to present results from HOPE-2 trial of CAP-1002 in DMD »

Capricor Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEE

Ameren

$77.17

0.58 (0.76%)

07:03
09/17/19
09/17
07:03
09/17/19
07:03
Upgrade
Ameren rating change  »

BofA/Merrill upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 10

    Nov

CNPOF

Canopy Rivers

$0.00

(0.00%)

07:02
09/17/19
09/17
07:02
09/17/19
07:02
Hot Stocks
Canopy Rivers' TerrAscend enters distribution agreement with Syqe Medical »

Canopy Rivers is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBNC

Reliant Bancorp

$24.70

0.16 (0.65%)

07:02
09/17/19
09/17
07:02
09/17/19
07:02
Conference/Events
Reliant Bancorp to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 23

    Sep

LPTX

Leap Therapeutics

$1.81

0.035 (1.97%)

07:02
09/17/19
09/17
07:02
09/17/19
07:02
Hot Stocks
Leap Therapeutics announces update on Phase 2 clinical trial of DKN-01 »

Leap Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

AAPL

Apple

$219.88

1.17 (0.53%)

07:01
09/17/19
09/17
07:01
09/17/19
07:01
Periodicals
Apple challanges $14B tax charge from European Commission, CNBC reports »

Apple has challenged a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$15.76

-0.24 (-1.50%)

, FB

Facebook

$186.24

-0.73 (-0.39%)

07:00
09/17/19
09/17
07:00
09/17/19
07:00
Upgrade
Susquehanna upgrades Snap to Neutral after positive advertising checks »

Susquehanna analyst Shyam…

SNAP

Snap

$15.76

-0.24 (-1.50%)

FB

Facebook

$186.24

-0.73 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

MDR

McDermott

$6.08

0.28 (4.83%)

06:58
09/17/19
09/17
06:58
09/17/19
06:58
Hot Stocks
McDermott joint venture awarded module fabrication contract »

McDermott announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

AEE

Ameren

$77.17

0.58 (0.76%)

06:57
09/17/19
09/17
06:57
09/17/19
06:57
Upgrade
Ameren rating change  »

Ameren upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 10

    Nov

MCFT

MasterCraft Boat Holdings

$14.41

-0.1 (-0.69%)

06:55
09/17/19
09/17
06:55
09/17/19
06:55
Conference/Events
MasterCraft Boat Holdings to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

OSMT

Osmotica Pharmaceuticals

$3.84

0.15 (4.07%)

06:51
09/17/19
09/17
06:51
09/17/19
06:51
Hot Stocks
Osmotica subsidiary submits NDA to FDA for RVL-1201 »

Vertical Pharmaceuticals,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAST

Eastside Distilling

$4.97

-0.03 (-0.60%)

06:51
09/17/19
09/17
06:51
09/17/19
06:51
Conference/Events
Eastside Distilling to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

ADS

Alliance Data

$132.88

-1.11 (-0.83%)

, SBH

Sally Beauty

$14.47

-0.12 (-0.82%)

06:49
09/17/19
09/17
06:49
09/17/19
06:49
Hot Stocks
Alliance Data signs agreement to provide credit card services for Sally Beauty »

Alliance Data (ADS) has…

ADS

Alliance Data

$132.88

-1.11 (-0.83%)

SBH

Sally Beauty

$14.47

-0.12 (-0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 23

    Sep

  • 13

    Nov

  • 03

    Dec

KAMN

Kaman

$63.22

0.55 (0.88%)

06:49
09/17/19
09/17
06:49
09/17/19
06:49
Hot Stocks
Kaman awarded $42M order of Joint Programmable Fuzes »

Kaman announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYME

Zymeworks

$25.84

0.19 (0.74%)

06:49
09/17/19
09/17
06:49
09/17/19
06:49
Hot Stocks
Zymeworks names Lota Zoth as board Chair, voluntarily delists from TSX »

Zymeworks announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

SBH

Sally Beauty

$14.47

-0.12 (-0.82%)

, ADS

Alliance Data

$132.88

-1.11 (-0.83%)

06:47
09/17/19
09/17
06:47
09/17/19
06:47
Hot Stocks
Sally Beauty signs agreement with Alliance Data's card services business »

Sally Beauty Holdings…

SBH

Sally Beauty

$14.47

-0.12 (-0.82%)

ADS

Alliance Data

$132.88

-1.11 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 23

    Sep

  • 13

    Nov

  • 03

    Dec

MRK

Merck

$82.01

-0.6 (-0.73%)

06:47
09/17/19
09/17
06:47
09/17/19
06:47
Hot Stocks
Merck: FDA accepts BLA, grants priority review for investigational Ebola vaccine »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 29

    Oct

XLRN

Acceleron

$44.67

0.75 (1.71%)

06:43
09/17/19
09/17
06:43
09/17/19
06:43
Recommendations
Acceleron analyst commentary  »

Acceleron should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 04

    Dec

  • 04

    Apr

CBMG

Cellular Biomedicine

$14.75

-0.16 (-1.07%)

06:43
09/17/19
09/17
06:43
09/17/19
06:43
Initiation
Cellular Biomedicine initiated  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.